首页> 外文期刊>Journal of Clinical and Diagnostic Research >XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study
【24h】

XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study

机译:XIAP和Ki-67:涎腺良性和恶性肿瘤中抗凋亡和增殖标记物表达之间的相关性:免疫组织化学研究

获取原文
获取外文期刊封面目录资料

摘要

Background: Impaired balance between cell proliferation and apoptosis is crucial to the development of malignant neoplasm. The purpose of this study was to evaluate and compare the expression of X-Linked inhibitor of apoptotic protein (XIAP) (antiapoptotic marker) and Ki-67 (proliferative marker) expression in benign and malignant salivary gland (SG) tumours. Materials and Methods: The study consisted of 40 cases of benign SG tumours and 50 cases of malignant SG tumours. The immunohistochemistry was carried out by using Ki-67 antibody (clone MIB-1) and XIAP antibody in all the groups. Results: XIAP expression was significantly higher in malignant SG tumours than benign SG tumours (p = 0.016). Ki-67 LI was significantly higher in malignant SG tumours than benign SG tumours (p = 0.0002). Statistically significant positive correlation between Ki-67 count and XIAP expression was noted in benign and malignant SG tumours (p = 0.000). Conclusion: As the expression of an antiapoptotic marker (XIAP) increases, the expression of a proliferative marker (Ki-67) also increases from benign to malignant SG tumours. Thus, targeted therapy of XIAP may play a future role in the management of SG malignancy.
机译:背景:细胞增殖与凋亡之间的平衡受损对恶性肿瘤的发展至关重要。这项研究的目的是评估和比较X连锁凋亡蛋白(XIAP)(抗凋亡标记物)和Ki-67(增殖性标记物)在良性和恶性涎腺(SG)肿瘤中的表达。材料与方法:本研究包括40例良性SG肿瘤和50例恶性SG肿瘤。在所有组中均使用Ki-67抗体(克隆MIB-1)和XIAP抗体进行免疫组织化学。结果:在恶性SG肿瘤中XIAP表达显着高于良性SG肿瘤(p = 0.016)。 Ki-67 LI在恶性SG肿瘤中显着高于良性SG肿瘤(p = 0.0002)。在良性和恶性SG肿瘤中,Ki-67计数与XIAP表达之间存在统计学上的显着正相关(p = 0.000)。结论:随着抗凋亡标记物(XIAP)的表达增加,增殖性标记物(Ki-67)的表达也从良性变为恶性SG肿瘤。因此,XIAP的靶向治疗可能在SG恶性肿瘤的治疗中发挥未来作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号